Abstract
Determining the penetration of drugs across the bloodbrain barrier is a significant challenge in central nervous system drug development. The use of a mechanistic physiologically based pharmacokinetic model can predict drug exposures in the brain without needing in situ drug measurements.
| Original language | English |
|---|---|
| Pages (from-to) | 7437-7439 |
| Number of pages | 3 |
| Journal | Clinical Cancer Research |
| Volume | 23 |
| Issue number | 24 |
| DOIs | |
| State | Published - 15 Dec 2017 |
| Externally published | Yes |